Singapore markets close in 4 hours 51 minutes

BioCryst Pharmaceuticals, Inc. (BCRX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
10.26-0.42 (-3.93%)
At close: 04:00PM EST
10.29 +0.03 (+0.29%)
After hours: 07:27PM EST
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
Total revenue
238,440
157,170
17,812
48,835
Cost of revenue
4,517
7,264
1,676
4,101
Gross profit
233,923
149,906
16,136
44,734
Operating expenses
Research development
243,619
208,808
122,964
107,068
Selling general and administrative
144,605
118,818
67,929
37,121
Total operating expenses
388,224
327,626
190,893
144,189
Operating income or loss
-154,301
-177,720
-174,757
-99,455
Interest expense
91,414
59,294
14,501
11,892
Total other income/expenses net
54,834
55,143
-2,976
517
Income before tax
-188,444
-181,809
-182,814
-108,897
Income tax expense
4,910
2,253
-
-
Income from continuing operations
-193,354
-184,062
-182,814
-108,897
Net income
-193,354
-184,062
-182,814
-108,897
Net income available to common shareholders
-193,354
-184,062
-182,814
-108,897
Basic EPS
-
-1.03
-1.09
-0.94
Diluted EPS
-
-1.03
-1.09
-0.94
Basic average shares
-
179,117
167,267
115,600
Diluted average shares
-
179,117
167,267
115,600
EBITDA
-
-121,738
-167,565
-96,281